Melatonin (Melocirc)
Melatonin
Pharma Dynamics (Pty) Ltd
Registration
- Applicant
- Pharma Dynamics (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Melocirc EACH TABLET CONTAINS: MELATONIN 2,0 mg | Not listed | 58011558/2.2/0115 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Melatonin
- except when used for the treatment of desyncronosis (jet-lag) in doses not exceeding 6 milligrams daily. (S2).
Consolidated Schedules 06 July 2026, lines 7043 to 7044
S2: Melatonin
- when used for the treatment of desyncronosis (jet-lag) in doses not exceeding 6 milligrams daily.
Consolidated Schedules 06 July 2026, line 2282
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
Drag to rotate. Structure from PubChem CID 896.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.